TOPICORT LP Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Topicort Lp, and what generic alternatives are available?
Topicort Lp is a drug marketed by Taro and is included in one NDA.
The generic ingredient in TOPICORT LP is desoximetasone. There are seven drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the desoximetasone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Topicort Lp
A generic version of TOPICORT LP was approved as desoximetasone by PADAGIS ISRAEL on July 1st, 2003.
Summary for TOPICORT LP
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 65 |
Clinical Trials: | 4 |
Patent Applications: | 5,117 |
DailyMed Link: | TOPICORT LP at DailyMed |
Recent Clinical Trials for TOPICORT LP
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Wake Forest University Health Sciences | Phase 4 |
Psoriasis Treatment Center of Central New Jersey | Phase 4 |
Taro Pharmaceuticals USA | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for TOPICORT LP
US Patents and Regulatory Information for TOPICORT LP
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Taro | TOPICORT LP | desoximetasone | CREAM;TOPICAL | 018309-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |